203 related articles for article (PubMed ID: 34394099)
1. IL-10 Deficiency Accelerates Type 1 Diabetes Development
Huang J; Tan Q; Tai N; Pearson JA; Li Y; Chao C; Zhang L; Peng J; Xing Y; Zhang L; Hu Y; Zhou Z; Wong FS; Wen L
Front Immunol; 2021; 12():702955. PubMed ID: 34394099
[TBL] [Abstract][Full Text] [Related]
2. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
[TBL] [Abstract][Full Text] [Related]
3. Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development.
Yu H; Gagliani N; Ishigame H; Huber S; Zhu S; Esplugues E; Herold KC; Wen L; Flavell RA
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10443-10448. PubMed ID: 28894001
[TBL] [Abstract][Full Text] [Related]
4. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.
Esensten JH; Lee MR; Glimcher LH; Bluestone JA
J Immunol; 2009 Jul; 183(1):75-82. PubMed ID: 19535634
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
Front Immunol; 2019; 10():1733. PubMed ID: 31417546
[TBL] [Abstract][Full Text] [Related]
6. Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes.
Gudi R; Perez N; Johnson BM; Sofi MH; Brown R; Quan S; Karumuthil-Melethil S; Vasu C
Immunology; 2019 May; 157(1):70-85. PubMed ID: 30712258
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota-Stimulated Innate Lymphoid Cells Support β-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes.
Miani M; Le Naour J; Waeckel-Enée E; Verma SC; Straube M; Emond P; Ryffel B; van Endert P; Sokol H; Diana J
Cell Metab; 2018 Oct; 28(4):557-572.e6. PubMed ID: 30017352
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
Balasa B; Lee J; Sarvetnick N
Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
[TBL] [Abstract][Full Text] [Related]
9. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic and Immunoregulatory Activities of Extract of
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373070
[TBL] [Abstract][Full Text] [Related]
11. B6.g7 mice reconstituted with BDC2·5 non-obese diabetic (BDC2·5NOD) stem cells do not develop autoimmune diabetes.
Rajasekaran N; Wang N; Hang Y; Macaubas C; Rinderknecht C; Beilhack GF; Shizuru JA; Mellins ED
Clin Exp Immunol; 2013 Oct; 174(1):27-37. PubMed ID: 23795893
[TBL] [Abstract][Full Text] [Related]
12. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
Pearson JA; Wong FS; Wen L
J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
[TBL] [Abstract][Full Text] [Related]
14. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
15. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
16. Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese diabetic mice.
Bellemore SM; Nikoopour E; Schwartz JA; Krougly O; Lee-Chan E; Singh B
Clin Exp Immunol; 2015 Dec; 182(3):261-9. PubMed ID: 26250153
[TBL] [Abstract][Full Text] [Related]
17. TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells.
Gülden E; Chao C; Tai N; Pearson JA; Peng J; Majewska-Szczepanik M; Zhou Z; Wong FS; Wen L
J Autoimmun; 2018 Sep; 93():57-65. PubMed ID: 29960834
[TBL] [Abstract][Full Text] [Related]
18. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
Balasa B; Van Gunst K; Sarvetnick N
Clin Immunol; 2000 May; 95(2):93-8. PubMed ID: 10779402
[TBL] [Abstract][Full Text] [Related]
19. Early-life exposure to gut microbiota from disease-protected mice does not impact disease outcome in type 1 diabetes susceptible NOD mice.
Mullaney JA; Stephens JE; Geeling BE; Hamilton-Williams EE
Immunol Cell Biol; 2019 Jan; 97(1):97-103. PubMed ID: 30191611
[TBL] [Abstract][Full Text] [Related]
20. Activation-induced cytidine deaminase deficiency accelerates autoimmune diabetes in NOD mice.
Tan Q; Tai N; Li Y; Pearson J; Pennetti S; Zhou Z; Wong FS; Wen L
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
